{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:27:28Z","timestamp":1792744048065,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.lanwpc.2022.100601","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T10:17:04Z","timestamp":1664187424000},"page":"100601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1985-6303","authenticated-orcid":false,"given":"James F.","family":"Mbinta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6203-6664","authenticated-orcid":false,"given":"Binh P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Paynter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper Mandela A.","family":"Awuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Pine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Sporle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2022.100601_bib0001","series-title":"Plotkin's Vaccines","first-page":"1268","article-title":"Zoster vaccines","author":"Levin","year":"2018"},{"issue":"25","key":"10.1016\/j.lanwpc.2022.100601_bib0002","first-page":"265","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"suppl_1","key":"10.1016\/j.lanwpc.2022.100601_bib0003","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1093\/ofid\/ofx163.733","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"4","author":"Kawai","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100601_bib0004","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.lanwpc.2022.100601_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.lanwpc.2022.100601_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-021241","article-title":"Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm","volume":"8","author":"Turner","year":"2018","journal-title":"BMJ Open"},{"issue":"1407","key":"10.1016\/j.lanwpc.2022.100601_bib0007","first-page":"56","article-title":"Herpes zoster (shingles) at a large New Zealand general practice: incidence over 5 years","volume":"127","author":"Reid","year":"2014","journal-title":"N Zeal Med J (Online)"},{"issue":"16","key":"10.1016\/j.lanwpc.2022.100601_bib0008","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Postherpetic neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"issue":"22","key":"10.1016\/j.lanwpc.2022.100601_bib0010","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.vaccine.2019.04.014","article-title":"The comparative efficacy and safety of herpes zoster vaccines: a network meta-analysis","volume":"37","author":"McGirr","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100601_bib0011","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/hv.36160","article-title":"Evaluation of the economic burden of Herpes Zoster (HZ) infection","volume":"11","author":"Panatto","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.lanwpc.2022.100601_bib0012","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"Morb Mortal Wkly Rep: Recommend Rep"},{"issue":"3","key":"10.1016\/j.lanwpc.2022.100601_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0014","doi-asserted-by":"crossref","first-page":"k4029","DOI":"10.1136\/bmj.k4029","article-title":"Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis","volume":"363","author":"Tricco","year":"2018","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.lanwpc.2022.100601_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040964","article-title":"Postlicensure herpes zoster vaccine effectiveness: systematic review protocol","volume":"11","author":"Mbinta","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.lanwpc.2022.100601_bib0016","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/S2666-7568(22)00039-3","article-title":"Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis","volume":"3","author":"Mbinta","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0017","unstructured":"Ministry of Health. National health index 2020 Available from:https:\/\/www.health.govt.nz\/our-work\/health-identity\/national-health-index."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0018","unstructured":"Ministry of Health. National minimum dataset (hospital events) 2021 Available from:https:\/\/www.health.govt.nz\/nz-health-statistics\/national-collections-and-surveys\/collections\/national-minimum-dataset-hospital-events."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0019","unstructured":"Ministry of Health. National immunisation register 2021."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0020","unstructured":"Ministry of Health. Pharmaceutical collection 2021 Available from:https:\/\/www.health.govt.nz\/nz-health-statistics\/national-collections-and-surveys\/collections\/pharmaceutical-collection."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0021","unstructured":"Ministry of Health. New Zealand cancer registry - what is collected 2021."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0022","series-title":"Mortality collection wellington","year":"2021"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0023","series-title":"NZDep2013 Index of Deprivation","author":"Atkinson","year":"2014"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0024","series-title":"Higher Education: Handbook of Theory and Research","first-page":"47","article-title":"The use of matching methods in higher education research: answering whether attendance at a 2-year institution results in differences in educational attainment","author":"Reynolds","year":"2009"},{"issue":"9","key":"10.1016\/j.lanwpc.2022.100601_bib0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamaophthalmol.2016.2166","article-title":"Assessment of the accuracy of using ICD-9 codes to identify uveitis, herpes zoster ophthalmicus, scleritis, and episcleritis","volume":"134","author":"Pimentel","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.lanwpc.2022.100601_bib0026","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr206","article-title":"Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?","volume":"174","author":"Yawn","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"36","key":"10.1016\/j.lanwpc.2022.100601_bib0027","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1016\/j.vaccine.2019.07.004","article-title":"Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention","volume":"37","author":"Klein","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.lanwpc.2022.100601_bib0028","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1071\/HC14108","article-title":"Herpes zoster: when do patients present and who gets antiviral treatment?","volume":"6","author":"Wallis","year":"2014","journal-title":"J Prim Health Care"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0029","unstructured":"bpacnz. Valaciclovir \u2013 a first line antiviral medicine: bpacnz; 2017 Available from: https:\/\/bpac.org.nz\/BPJ\/2016\/March\/valaciclovir.aspx."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/CLEP.S129879","article-title":"Confounding in observational studies based on large health care databases: problems and potential solutions - a primer for the clinician","volume":"9","author":"N\u00f8rgaard","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.lanwpc.2022.100601_bib0031","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/infdis\/jis334","article-title":"Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population","volume":"206","author":"Tseng","year":"2012","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.lanwpc.2022.100601_bib0032","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/ciw854","article-title":"Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the medicare population ages 65 years and older","volume":"64","author":"Izurieta","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.lanwpc.2022.100601_bib0033","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2018.02.021","article-title":"Effectiveness of herpes zoster vaccination in an older United Kingdom population","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.lanwpc.2022.100601_bib0034","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1016\/j.vaccine.2018.08.037","article-title":"Assessing the effectiveness of zoster vaccine live: a retrospective cohort study using primary care data in the United Kingdom","volume":"36","author":"Matthews","year":"2018","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.lanwpc.2022.100601_bib0035","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0036","series-title":"R: A Language and Environment for Statistical Computing","year":"2019"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0037","series-title":"Python 3 Reference Manual","author":"Rossum","year":"2009"},{"issue":"11","key":"10.1016\/j.lanwpc.2022.100601_bib0038","article-title":"Vaccines for preventing herpes zoster in older adults","author":"Gagliardi","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0039","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/infdis\/jiy263","article-title":"Use of real-world evidence to evaluate the effectiveness of herpes zoster vaccine","volume":"218","author":"Tseng","year":"2018","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.lanwpc.2022.100601_bib0040","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med"},{"issue":"48","key":"10.1016\/j.lanwpc.2022.100601_bib0041","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.vaccine.2013.07.006","article-title":"Vaccine effects and impact of vaccination programmes in post-licensure studies","volume":"31","author":"Hanquet","year":"2013","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.lanwpc.2022.100601_bib0042","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.vaccine.2021.01.067","article-title":"Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia","volume":"39","author":"Lin","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.lanwpc.2022.100601_bib0043","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/cid\/ciu501","article-title":"Editorial commentary: zoster vaccine in immunocompromised patients: time to reconsider current recommendations","volume":"59","author":"Oxman","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.lanwpc.2022.100601_bib0044","doi-asserted-by":"crossref","first-page":"S743","DOI":"10.1093\/ofid\/ofy210.2134","article-title":"Impact of sex and race\/ethnicity on the effectiveness of live zoster vaccine","volume":"5","author":"Marks","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0045","unstructured":"Ministry of Health. Annual data explorer 2020\/21: new zealand health survey [Data File] 2021. Available from:https:\/\/minhealthnz.shinyapps.io\/nz-health-survey-2020-21-annual-data-explorer\/."},{"key":"10.1016\/j.lanwpc.2022.100601_bib0046","series-title":"Wai 2575 M\u0101ori Health Trends Report","year":"2019"},{"issue":"1538","key":"10.1016\/j.lanwpc.2022.100601_bib0047","first-page":"28","article-title":"M\u0101ori and pacific people in New Zealand have higher risk of hospitalisation for COVID-19","volume":"134","author":"Steyn","year":"2021","journal-title":"N Zeal Med J"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0048","series-title":"ID Week","first-page":"2","article-title":"Assessment of the accuracy of clinical diagnosis of herpes zoster by polymerase chain reaction","author":"Tseng","year":"2013"},{"key":"10.1016\/j.lanwpc.2022.100601_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-021-01423-4","article-title":"The enrolment gap: who is not enrolling with primary health organizations in Aotearoa New Zealand and what are the implications? An exploration of 2015\u20132019 administrative data","volume":"20","author":"Irurzun-Lopez","year":"2021","journal-title":"Int J Equity Health"},{"issue":"7","key":"10.1016\/j.lanwpc.2022.100601_bib0049","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/pds.4801","article-title":"Zostavax vaccine effectiveness among US elderly using real-world evidence: addressing unmeasured confounders by using multiple imputation after linking beneficiary surveys with Medicare claims","volume":"28","author":"Izurieta","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.lanwpc.2022.100601_bib0050","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100601_bib0051","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwx245","article-title":"Long-term effectiveness of the live zoster vaccine in preventing shingles: a cohort study","volume":"187","author":"Baxter","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.lanwpc.2022.100601_bib0052","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100601_bib0053","unstructured":"World Health Organisation. Disability and health: World Health Organisation; 2022 Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/disability-and-health."},{"issue":"6","key":"10.1016\/j.lanwpc.2022.100601_bib0054","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.annepidem.2016.04.006","article-title":"Self-reported herpes zoster, pain, and health care seeking in the health and retirement study: implications for interpretation of health care-based studies","volume":"26","author":"Hales","year":"2016","journal-title":"Ann Epidemiol"},{"issue":"6","key":"10.1016\/j.lanwpc.2022.100601_bib0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.lanwpc.2022.100601_bib0056","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:50:49Z","timestamp":1719708649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606522002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":57,"alternative-id":["S2666606522002164"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100601","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100601"}}